Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    Steatohepatitis and liver cirrhosis in Chanarin-Dorfman syndrome with a new ABDH5 mutation.

    Cakmak E, Alagozlu H, Yonem O, Ataseven H, Citli S, Ozer H.

    Clin Res Hepatol Gastroenterol. 2012 Apr;36(2):e34-7. Epub 2012 Jan 13.

    PMID:
    22245374
    [PubMed - in process]
    2.

    Primary biliary cirrhosis: bad genes, bad luck.

    Invernizzi P, Gershwin ME.

    Dig Dis Sci. 2012 Mar;57(3):599-601. No abstract available.

    PMID:
    22246164
    [PubMed - indexed for MEDLINE]
    3.

    Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT.

    Park JJ, Park JY, Kim do Y, Park YN, Ahn SH, Chon CY, Han KH.

    Hepatogastroenterology. 2011 Jul-Aug;58(109):1321-7. doi: 10.5754/hge11041.

    PMID:
    21937403
    [PubMed - indexed for MEDLINE]
    4.

    Chronic hepatitis C treated with peginterferon alfa plus ribavirin in clinical practice.

    Velosa J, Serejo F, Bana T, Redondo I, Simão A, Vale AM, Pires S, Macedo G, Marinho R, Peixe P, Sarmento J, Matos L, Calinas F, Carvalho A, Figueiredo A.

    Hepatogastroenterology. 2011 Jul-Aug;58(109):1260-6. doi: 10.5754/hge10239.

    PMID:
    21937391
    [PubMed - indexed for MEDLINE]
    5.

    Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.

    Boonstra K, Beuers U, Ponsioen CY.

    J Hepatol. 2012 May;56(5):1181-8. Epub 2012 Jan 13.

    PMID:
    22245904
    [PubMed - in process]
    6.

    Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.

    Pereira G, Guevara M, Fagundes C, Solá E, Rodríguez E, Fernández J, Pavesi M, Arroyo V, Ginès P.

    J Hepatol. 2012 May;56(5):1040-6. Epub 2012 Jan 13.

    PMID:
    22245902
    [PubMed - in process]
    7.

    Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.

    Cucchetti A, Trevisani F, Cescon M, Ercolani G, Farinati F, Poggio PD, Rapaccini G, Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Pinna AD; Italian Liver Cancer (ITA.LI.CA) Group.

    J Hepatol. 2012 May;56(5):1089-96. Epub 2012 Jan 13.

    PMID:
    22245900
    [PubMed - in process]
    8.

    The impact of organ dysfunction in cirrhosis: survival at a cost?

    Shawcross DL, Austin MJ, Abeles RD, McPhail MJ, Yeoman AD, Taylor NJ, Portal AJ, Jamil K, Auzinger G, Sizer E, Bernal W, Wendon JA.

    J Hepatol. 2012 May;56(5):1054-62. Epub 2012 Jan 13.

    PMID:
    22245890
    [PubMed - in process]
    9.

    PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats.

    Rodríguez-Vilarrupla A, Laviña B, García-Calderó H, Russo L, Rosado E, Roglans N, Bosch J, García-Pagán JC.

    J Hepatol. 2012 May;56(5):1033-9. Epub 2012 Jan 13.

    PMID:
    22245887
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk